Mebudipine and dibudipine protect PC12 cells against oxygen-glucose deprivation and glutamate-induced cell death

Pathophysiology

Volumn 15, Issue 4, 2008, Pages 227-231

  Rahbar Roshandel, Nahid ^a   Razavi, Lili ^b   Tavakoli Far, Bahareh ^a   Mahmoudian, Massoud ^a  

^a IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b University of Economic Sciences   (Iran)

Author keywords

Dibudipine; Glutamate; Mebudipine; Oxygen glucose deprivation; PC12 cell line

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL L TYPE; DIBUDIPINE; DIZOCILPINE; GLUCOSE; GLUTAMIC ACID; MEBUDIPINE; NIMODIPINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BRAIN HYPOXIA; BRAIN OXYGEN TENSION; BRAIN PROTECTION; CELL DAMAGE; CELL DEATH; CELL STRAIN; CELL VIABILITY; GLUCOSE BRAIN LEVEL; NERVE CELL CULTURE; NEUROPROTECTION; NEUROTOXICITY; NITROBLUE TETRAZOLIUM TEST; NONHUMAN; PHEOCHROMOCYTOMA CELL; PRIORITY JOURNAL; RAT;

EID: 56649085093     PISSN: 09284680     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pathophys.2008.09.002     Document Type: Article

References (27)

1. Bleich S., Romer K., Wiltfang J., and Kornhuber J. Glutamate and the glutamate receptor system: a target for drug action. Int. J. Geriatr. Psychiatry 18 (2003) S33-S40
2. Conn P.J. Physiological roles and therapeutic potential of metabotropic glutamate receptors. Ann. N. Y. Acad. Sci. 1003 (2003) 12-21
3. Olnay J.W. Excitotoxic amino acids and neuropsychiatric disorder. Annu. Rev. Pharmacol. Toxicol. 30 (1990) 47-71 (Review)
4. Smith W.S. Pathophysiology of focal cerebral ischemia: a therapeutic perspective. J. Vasc. Interv. Radiol. 15 1 Pt 2 (2004) S3-S12
5. Lipton P. Ischemic cell death in brain neurons. Physiol. Rev. 79 (1999) 1431-1568
6. Beckman J.S. The double-edged role of nitric oxide in brain function and superoxide mediated injury. J. Dev. Physiol. 15 (1991) 53-59
7. Choi D.W. Calcium-mediated neurotoxicity: relationship to specific channel types and role in ischemic damage. Trends Neurosci. 11 (1988) 465-469
8. Iwai M., Chen R., Ide A., Iwanami J., Tomochika H., Tomono Y., Mogi M., and Horiuchi M. The calcium-channel blocker, azelnidipine, enhances the inhibitory action of AT1 rec eptor blockade on ischemic brain damage. J. Hypertens. 24 10 (2006) 2023-2031
9. Havashi T., Shoji M., and Abe K. Molecular mechanisms of ischemic neuronal cell death-with relevance to Alzheimer's disease. Curr. Alzheimer Res. 3 4 (2006) 351-358
10. Fleckenstien A. Specific pharmacology of calcium in myocardium, cardiac pacemakers, and vascular smooth muscle. Annu. Rev. Pharmacol. Toxicol. 17 (1977) 149-166
11. Mahmoudian M., Mirkhani H., Nehardani Z., and Ghaiee S. Synthesis and biological activity of two new calcium-channel blockers, mebudipine, and dibudipine. J. Pharm. Pharmacol. 49 (1997) 1229-1233
12. S. Bohlooli, The study of the pharmacokinetics properties of mebudipine and dibudipine, two new calcium-channel blockers, Ph.D dissertation, Iran University of Medical Sciences Tehran, 2003.
13. Mirkhani H., Omrani G.R., Ghiaee S., and Mahmoudiam M. Effect of mebudipine and dibudipine, two new calcium-channel blockers, on rat left atrium, rat blood pressure and human internal mammary artery. J. Pharm. Pharmacol. 51 (1999) 617-622
14. Rahbar-Roshandel N., Razavi L., and Tavakoli-Far B. Nimodipine protects PC12 cells against oxygen-glucose deprivation. IJPT 6 (2007) 51-54
15. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65 (1983) 55-63
16. Frantseva M.V., Carlen P.L., and El-Beheiry H. A submersion method to induce hypoxic damage in organotypic hippocampal cultures. J. Neurosci. Methods 89 (1999) 25-31
17. Kornekov A.L., Pahnake J., Frei K., Warzok R., Schroder H.W., Frick R., Muljana L., Piek J., and Yonekawa Y. Treatment with nimodipine and mannitol reduces programed cell and infarct size following focal cerebral ischemia. Neurosurg. Rev. 23 (2000) 145-150
18. Greene L.A.G., and Rein G. Short-term regulation of catecholamine biosynthesis in a nerve growth factor responsive clonal line of rat pheochromocytoma cells. J. Neurochem. 30 3 (1978) 549-555
19. Choi D.W. Ionic dependence of glutamate neurotoxicity. J. Neurosci. 7 (1987) 369-379
20. Ankarcrona M., Dypbukt J.M., Bonfoco E., Zhivotovsky B., Orrenius S., Lipton S.A., and Nicotera P. Glutamate-induced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function. Neuron 15 (1995) 961-973
21. Rothman S.M., and Olney J.W. Glutamate and pathophysiology of hypoxic ischemic brain damage. Ann. Neural. 19 (1986) 105-111
22. Szatkowski M., and Attwell D. Triggering and execution of neuronal death in brain ischaemia: two phases of glutamate release by different mechanisms. Trends Neurosci. 17 (1994) 359-365
23. Jabaudon D., Scanziani M., Gahwiler B.H., and Gerber U. Acute decrease in net glutamate uptake during energy deprivation. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 5610-5615
24. 2+] in hypoxia and ischemia in rat brain in vivo. J. Gen. Physiol. 5 (1990) 837-866
25. Choi D.W., and Rothman S.M. The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death. Annu. Rev. Neurosci. 13 (1990) 171-182
26. Kritian T., and Siesjo B.K. Calcium-related damage in ischemia. Life Sci. 59 (1996) 357-367
27. Nishizawa Y. Glutamate release and neuronal damage in ischemia. Life Sci. 69 (2001)